1	Federal	JJ	3	amod
2	drug	NN	3	nn
3	regulators	NNS	21	nsubj
4	,	,	3	punct
5	concerned	VBN	3	amod
6	over	IN	5	prep
7	British	JJ	8	amod
8	reports	NNS	6	pobj
9	that	IN	12	complm
10	diabetics	NNS	12	nsubj
11	have	VBP	12	aux
12	died	VBN	8	ccomp
13	after	IN	12	prep
14	shifting	VBG	13	pcomp
15	from	IN	14	prep
16	animal	JJ	15	pobj
17	to	TO	14	prep
18	human-based	JJ	19	amod
19	insulin	NN	17	pobj
20	,	,	3	punct
21	say	VBP	0	root
22	they	PRP	24	nsubj
23	are	VBP	24	aux
24	considering	VBG	21	ccomp
25	a	DT	26	det
26	study	NN	24	dobj
27	to	TO	28	aux
28	see	VB	26	infmod
29	if	IN	33	mark
30	similar	JJ	31	amod
31	deaths	NNS	33	nsubj
32	have	VB	33	aux
33	occurred	VBN	28	advcl
34	here	RB	33	advmod
35	.	.	21	punct

1	The	DT	4	det
2	United	NNP	3	nn
3	Kingdom	NNP	4	nn
4	reports	NNS	5	nsubj
5	came	VBD	0	root
6	from	IN	5	prep
7	Dr.	NNP	9	nn
8	Patrick	NNP	9	nn
9	Toseland	NNP	6	pobj
10	,	,	9	punct
11	head	NN	9	appos
12	of	IN	11	prep
13	clinical	JJ	14	amod
14	chemistry	NN	12	pobj
15	at	IN	11	prep
16	Guy	NNP	18	poss
17	's	POS	16	possessive
18	Hospital	NNP	15	pobj
19	in	IN	18	prep
20	London	NNP	19	pobj
21	.	.	5	punct

1	In	IN	9	prep
2	a	DT	4	det
3	telephone	NN	4	nn
4	interview	NN	1	pobj
5	Friday	NNP	9	tmod
6	,	,	9	punct
7	Dr.	NNP	8	nn
8	Toseland	NNP	9	nsubj
9	said	VBD	0	root
10	the	DT	11	det
11	number	NN	25	nsubj
12	of	IN	11	prep
13	sudden	JJ	16	amod
14	,	,	16	punct
15	unexplained	JJ	16	amod
16	deaths	NNS	12	pobj
17	of	IN	16	prep
18	diabetics	NNS	17	pobj
19	he	PRP	21	nsubj
20	had	VBD	21	aux
21	seen	VBN	11	rcmod
22	this	DT	23	det
23	year	NN	21	tmod
24	was	VBD	25	cop
25	17	CD	9	ccomp
26	compared	VBN	25	prep
27	with	IN	26	pcomp
28	just	RB	29	advmod
29	two	CD	27	pobj
30	in	IN	29	prep
31	1985	CD	30	pobj
32	.	.	9	punct

1	At	IN	3	quantmod
2	least	JJS	1	mwe
3	six	CD	7	nsubj
4	of	IN	3	prep
5	the	DT	6	det
6	deaths	NNS	4	pobj
7	occurred	VBD	26	ccomp
8	among	IN	7	prep
9	relatively	RB	10	advmod
10	young	JJ	11	amod
11	diabetics	NNS	8	pobj
12	who	WP	14	nsubj
13	had	VBD	14	aux
14	switched	VBN	11	rcmod
15	from	IN	14	prep
16	animal	NN	15	pobj
17	to	TO	14	prep
18	human	JJ	19	amod
19	insulin	NN	17	pobj
20	within	IN	14	prep
21	the	DT	23	det
22	past	JJ	23	amod
23	year	NN	20	pobj
24	,	,	26	punct
25	he	PRP	26	nsubj
26	said	VBD	0	root
27	.	.	26	punct

1	Dr.	NNP	3	nn
2	Solomon	NNP	3	nn
3	Sobel	NNP	20	nsubj
4	,	,	3	punct
5	director	NN	3	appos
6	of	IN	5	prep
7	metabolism	NN	10	amod
8	and	CC	7	cc
9	endrocrine	JJ	7	conj
10	drug	NN	11	nn
11	products	NNS	6	pobj
12	for	IN	5	prep
13	the	DT	18	det
14	U.S.	NNP	18	nn
15	Food	NNP	18	nn
16	and	CC	15	cc
17	Drug	NNP	15	conj
18	Administration	NNP	12	pobj
19	,	,	3	punct
20	said	VBD	0	root
21	FDA	NNP	22	nn
22	officials	NNS	24	nsubj
23	have	VBP	24	aux
24	discussed	VBN	20	ccomp
25	Dr.	NNP	26	nn
26	Toseland	NNP	28	poss
27	's	POS	26	possessive
28	findings	NNS	24	dobj
29	``	``	24	punct
30	fairly	RB	31	advmod
31	intensively	RB	24	advmod
32	.	.	20	punct
33	''	''	20	punct

1	While	IN	6	mark
2	there	EX	6	expl
3	have	VBP	6	aux
4	been	VBN	6	cop
5	no	DT	6	det
6	reports	NNS	20	advcl
7	of	IN	6	prep
8	similar	JJ	11	amod
9	sudden	JJ	11	amod
10	unexplained	JJ	11	amod
11	deaths	NNS	7	pobj
12	among	IN	11	prep
13	diabetics	NNS	12	pobj
14	in	IN	13	prep
15	the	DT	16	det
16	U.S.	NNP	14	pobj
17	,	,	20	punct
18	Dr.	NNP	19	nn
19	Sobel	NNP	20	nsubj
20	said	VBD	0	root
21	the	DT	22	det
22	FDA	NNP	23	nsubj
23	plans	NNS	20	ccomp
24	to	TO	25	aux
25	examine	VB	23	xcomp
26	Dr.	NNP	27	nn
27	Toseland	NNP	29	poss
28	's	POS	27	possessive
29	evidence	NN	25	dobj
30	and	CC	23	cc
31	is	VBZ	32	aux
32	considering	VBG	23	conj
33	its	PRP$	35	poss
34	own	JJ	35	amod
35	study	NN	32	dobj
36	here	RB	35	advmod
37	.	.	20	punct

1	Dr.	NNP	2	nn
2	Toseland	NNP	7	nsubj
3	,	,	2	punct
4	a	DT	5	det
5	toxicologist	NN	2	appos
6	,	,	2	punct
7	said	VBD	0	root
8	he	PRP	10	nsubj
9	was	VBD	10	aux
10	preparing	VBG	7	ccomp
11	an	DT	12	det
12	article	NN	10	dobj
13	for	IN	10	prep
14	a	DT	18	det
15	British	JJ	18	amod
16	forensic	JJ	18	amod
17	medical	JJ	18	amod
18	journal	NN	13	pobj
19	raising	VBG	10	xcomp
20	the	DT	21	det
21	possibility	NN	19	dobj
22	that	IN	27	complm
23	the	DT	24	det
24	deaths	NNS	27	nsubj
25	may	MD	27	aux
26	have	VB	27	aux
27	occurred	VBN	21	ccomp
28	after	IN	31	mark
29	human	JJ	30	amod
30	insulin	NN	31	nsubj
31	blunted	VBD	27	advcl
32	critical	JJ	34	amod
33	warning	NN	34	nn
34	signs	NNS	31	dobj
35	indicating	VBG	34	partmod
36	hypoglycemia	NN	35	dobj
37	,	,	36	punct
38	or	CC	36	cc
39	low	JJ	41	amod
40	blood	NN	41	nn
41	sugar	NN	36	conj
42	,	,	36	punct
43	which	WDT	45	nsubj
44	can	MD	45	aux
45	kill	VB	36	rcmod
46	diabetics	NNS	45	dobj
47	.	.	7	punct

1	The	DT	4	det
2	usual	JJ	4	amod
3	warning	NN	4	nn
4	signs	NNS	7	nsubj
5	of	IN	4	prep
6	hypoglycemia	NN	5	pobj
7	include	VBP	0	root
8	sweating	NN	7	dobj
9	,	,	8	punct
10	anxiety	NN	8	conj
11	and	CC	8	cc
12	cramps	NNS	8	conj
13	.	.	7	punct

1	With	IN	8	prep
2	proper	JJ	3	amod
3	warning	NN	1	pobj
4	,	,	8	punct
5	diabetics	NNS	8	nsubj
6	can	MD	8	aux
7	easily	RB	8	advmod
8	raise	VB	0	root
9	their	PRP$	11	poss
10	blood	NN	11	nn
11	sugar	NN	8	dobj
12	to	TO	8	prep
13	safe	JJ	14	amod
14	levels	NNS	12	pobj
15	by	IN	8	prep
16	eating	VBG	15	pcomp
17	sugar	NN	16	dobj
18	or	CC	17	cc
19	sugary	JJ	20	amod
20	food	NN	17	conj
21	.	.	8	punct

1	``	``	25	punct
2	The	DT	4	det
3	anecdotal	JJ	4	amod
4	data	NN	6	nsubj
5	certainly	RB	6	advmod
6	shows	VBZ	25	ccomp
7	that	IN	14	complm
8	some	DT	14	nsubj
9	of	IN	8	prep
10	the	DT	11	det
11	people	NNS	9	pobj
12	were	VBD	14	cop
13	not	RB	14	neg
14	aware	JJ	6	ccomp
15	of	IN	14	prep
16	the	DT	18	det
17	rapid	JJ	18	amod
18	onset	NN	15	pobj
19	of	IN	18	prep
20	hypoglycemia	NN	19	pobj
21	,	,	25	punct
22	''	''	25	punct
23	Dr.	NNP	24	nn
24	Toseland	NNP	25	nsubj
25	said	VBD	0	root
26	.	.	25	punct

1	At	IN	21	prep
2	the	DT	5	det
3	U.S.	NNP	5	nn
4	National	NNP	5	nn
5	Institutes	NNP	1	pobj
6	of	IN	5	prep
7	Health	NNP	6	pobj
8	,	,	21	punct
9	Dr.	NNP	12	nn
10	Robert	NNP	12	nn
11	E.	NNP	12	nn
12	Silverman	NNP	21	nsubj
13	,	,	12	punct
14	chief	NN	12	appos
15	of	IN	14	prep
16	the	DT	19	det
17	diabetes	NN	18	nn
18	program	NN	19	nn
19	branch	NN	15	pobj
20	,	,	12	punct
21	said	VBD	0	root
22	no	DT	23	det
23	evidence	NN	30	nsubj
24	of	IN	23	prep
25	unexpected	JJ	26	amod
26	deaths	NNS	24	pobj
27	from	IN	26	prep
28	hypoglycemia	NN	27	pobj
29	had	VBD	30	aux
30	shown	VBN	21	ccomp
31	up	RP	30	prt
32	in	IN	30	prep
33	a	DT	34	det
34	study	NN	32	pobj
35	of	IN	34	prep
36	1,500	CD	37	num
37	diabetics	NNS	35	pobj
38	that	WDT	40	nsubj
39	has	VBZ	40	aux
40	been	VBN	34	rcmod
41	under	IN	40	prep
42	way	NN	41	pobj
43	at	IN	40	prep
44	NIH	NNP	43	pobj
45	for	IN	40	prep
46	five	CD	47	num
47	years	NNS	45	pobj
48	.	.	21	punct

1	However	RB	4	advmod
2	,	,	4	punct
3	he	PRP	4	nsubj
4	said	VBD	0	root
5	officials	NNS	12	nsubj
6	conducting	VBG	5	partmod
7	the	DT	8	det
8	study	NN	6	dobj
9	had	VBD	12	aux
10	n't	RB	12	neg
11	been	VBN	12	aux
12	looking	VBG	4	ccomp
13	for	IN	12	prep
14	signs	NNS	13	pobj
15	of	IN	14	prep
16	problems	NNS	15	pobj
17	related	VBN	16	amod
18	to	TO	17	prep
19	hypoglycemia	NN	20	nn
20	unawareness	NN	18	pobj
21	.	.	4	punct

1	``	``	14	punct
2	We	PRP	5	nsubj
3	are	VBP	5	aux
4	now	RB	5	advmod
5	monitoring	VBG	14	ccomp
6	for	IN	5	prep
7	it	PRP	6	pobj
8	much	RB	10	advmod
9	more	RBR	10	advmod
10	closely	RB	5	advmod
11	,	,	14	punct
12	''	''	14	punct
13	he	PRP	14	nsubj
14	said	VBD	0	root
15	.	.	14	punct

1	``	``	24	punct
2	We	PRP	4	nsubj
3	do	VBP	4	aux
4	know	VB	24	ccomp
5	there	EX	6	expl
6	are	VBP	4	ccomp
7	slight	JJ	8	amod
8	differences	NNS	6	nsubj
9	in	IN	8	prep
10	the	DT	11	det
11	way	NN	9	pobj
12	human	JJ	15	amod
13	and	CC	12	cc
14	animal	JJ	12	conj
15	insulins	NNS	16	nsubj
16	drive	VBP	11	rcmod
17	down	RP	16	prt
18	blood	NN	19	nn
19	sugar	NN	16	dobj
20	,	,	24	punct
21	''	''	24	punct
22	Dr.	NNP	23	nn
23	Sobel	NNP	24	nsubj
24	said	VBD	0	root
25	.	.	24	punct

1	The	DT	3	det
2	human-based	JJ	3	amod
3	drug	NN	4	nsubj
4	starts	VBZ	17	ccomp
5	the	DT	7	det
6	blood	NN	7	nn
7	sugar	NN	4	dobj
8	dropping	VBG	7	amod
9	sooner	RBR	4	advmod
10	and	CC	4	cc
11	drives	VBZ	4	conj
12	it	PRP	11	dobj
13	down	RP	11	prt
14	faster	RBR	11	advmod
15	,	,	17	punct
16	he	PRP	17	nsubj
17	said	VBD	0	root
18	.	.	17	punct

1	``	``	21	punct
2	But	CC	6	cc
3	we	PRP	6	nsubj
4	do	VBP	6	aux
5	n't	RB	6	neg
6	believe	VB	21	ccomp
7	there	EX	8	expl
8	is	VBZ	6	ccomp
9	enough	JJ	8	acomp
10	of	IN	9	prep
11	a	DT	12	det
12	difference	NN	10	pobj
13	to	TO	16	aux
14	be	VB	16	cop
15	clinically	RB	16	advmod
16	significant	JJ	9	xcomp
17	,	,	21	punct
18	''	''	21	punct
19	Dr.	NNP	20	nn
20	Sobel	NNP	21	nsubj
21	said	VBD	0	root
22	.	.	21	punct

1	Reports	NNS	12	nsubj
2	of	IN	1	prep
3	Dr.	NNP	4	nn
4	Toseland	NNP	6	poss
5	's	POS	4	possessive
6	findings	NNS	2	pobj
7	in	IN	1	prep
8	the	DT	10	det
9	British	JJ	10	amod
10	press	NN	7	pobj
11	have	VBP	12	aux
12	triggered	VBN	0	root
13	widespread	JJ	14	amod
14	concern	NN	12	dobj
15	among	IN	12	prep
16	diabetics	NNS	15	pobj
17	there	RB	16	advmod
18	.	.	12	punct

1	Both	DT	5	preconj
2	the	DT	5	det
3	British	NNP	5	nn
4	Diabetic	NNP	5	nn
5	Association	NNP	23	nsubj
6	and	CC	5	cc
7	the	DT	8	det
8	Committee	NNP	5	conj
9	on	IN	8	prep
10	Safety	NNP	9	pobj
11	in	IN	10	prep
12	Medicines	NNP	11	pobj
13	--	:	16	punct
14	Britain	NNP	16	poss
15	's	POS	14	possessive
16	equivalent	NN	8	dep
17	of	IN	16	prep
18	the	DT	20	det
19	U.S.	NNP	20	nn
20	FDA	NNP	17	pobj
21	--	:	16	punct
22	recently	RB	23	advmod
23	issued	VBD	0	root
24	statements	NNS	23	dobj
25	noting	VBG	24	partmod
26	the	DT	27	det
27	lack	NN	25	dobj
28	of	IN	27	prep
29	hard	JJ	31	amod
30	scientific	JJ	31	amod
31	evidence	NN	28	pobj
32	to	TO	33	aux
33	support	VB	31	infmod
34	Dr.	NNP	35	nn
35	Toseland	NNP	37	poss
36	's	POS	35	possessive
37	findings	NNS	33	dobj
38	.	.	23	punct

1	On	IN	8	prep
2	Friday	NNP	1	pobj
3	,	,	8	punct
4	the	DT	7	det
5	American	NNP	7	nn
6	Diabetes	NNP	7	nn
7	Association	NNP	8	nsubj
8	issued	VBD	0	root
9	a	DT	11	det
10	similar	JJ	11	amod
11	statement	NN	8	dobj
12	urging	VBG	11	partmod
13	the	DT	17	det
14	six	CD	15	number
15	million	CD	17	num
16	U.S.	NNP	17	nn
17	diabetics	NNS	12	dobj
18	not	RB	20	neg
19	to	TO	20	aux
20	overreact	VB	12	xcomp
21	to	TO	20	prep
22	the	DT	24	det
23	British	JJ	24	amod
24	report	NN	21	pobj
25	.	.	8	punct

1	``	``	33	punct
2	A	DT	3	det
3	loss	NN	13	nsubj
4	of	IN	3	prep
5	the	DT	7	det
6	warning	NN	7	nn
7	symptoms	NNS	4	pobj
8	of	IN	7	prep
9	hypoglycemia	NN	8	pobj
10	is	VBZ	13	cop
11	a	DT	13	det
12	complex	JJ	13	amod
13	problem	NN	33	ccomp
14	that	WDT	17	nsubj
15	is	VBZ	17	cop
16	very	RB	17	advmod
17	unlikely	JJ	13	rcmod
18	to	TO	19	aux
19	be	VB	17	xcomp
20	due	RB	19	advmod
21	simply	RB	22	advmod
22	to	TO	20	prep
23	the	DT	24	det
24	type	NN	22	pobj
25	of	IN	24	prep
26	insulin	NN	25	pobj
27	used	VBN	24	partmod
28	,	,	33	punct
29	''	''	33	punct
30	the	DT	32	det
31	American	JJ	32	amod
32	association	NN	33	nsubj
33	said	VBD	0	root
34	.	.	33	punct

1	The	DT	2	det
2	FDA	NNP	4	nsubj
3	already	RB	4	advmod
4	requires	VBZ	0	root
5	drug	NN	6	nn
6	manufacturers	NNS	8	nsubj
7	to	TO	8	aux
8	include	VB	4	xcomp
9	warnings	NNS	8	dobj
10	with	IN	8	prep
11	insulin	NN	12	nn
12	products	NNS	10	pobj
13	that	IN	19	complm
14	symptoms	NNS	19	nsubj
15	of	IN	14	prep
16	hypoglycemia	NN	15	pobj
17	are	VBP	19	cop
18	less	RBR	19	advmod
19	pronounced	JJ	8	ccomp
20	with	IN	19	prep
21	human	JJ	22	amod
22	insulin	NN	20	pobj
23	than	IN	19	prep
24	with	IN	23	pcomp
25	animal-based	JJ	26	amod
26	products	NNS	24	pobj
27	.	.	4	punct

1	Eli	NNP	2	nn
2	Lilly	NNP	11	nsubj
3	&	CC	2	cc
4	Co.	NNP	2	conj
5	,	,	2	punct
6	the	DT	9	det
7	Indianapolis-based	JJ	9	amod
8	drug	NN	9	nn
9	manufacturer	NN	2	appos
10	,	,	2	punct
11	dominates	VBZ	0	root
12	the	DT	16	det
13	U.S.	NNP	16	nn
14	human	JJ	16	amod
15	insulin	NN	16	nn
16	market	NN	11	dobj
17	with	IN	11	prep
18	its	PRP$	19	poss
19	product	NN	17	pobj
20	known	VBN	19	partmod
21	as	IN	20	prep
22	Humulin	NNP	21	pobj
23	.	.	11	punct

1	Lilly	NNP	3	nsubj
2	is	VBZ	3	aux
3	building	VBG	0	root
4	plants	NNS	3	dobj
5	to	TO	6	aux
6	make	VB	4	infmod
7	the	DT	8	det
8	insulin	NN	6	dobj
9	in	IN	3	prep
10	Indianapolis	NNP	9	pobj
11	and	CC	10	cc
12	Fagershein	NNP	10	conj
13	,	,	12	punct
14	France	NNP	12	appos
15	.	.	3	punct

1	In	IN	8	prep
2	its	PRP$	5	poss
3	latest	JJS	5	amod
4	annual	JJ	5	amod
5	report	NN	1	pobj
6	,	,	8	punct
7	Lilly	NNP	8	nsubj
8	said	VBD	0	root
9	Humulin	NNP	10	nn
10	sales	NNS	12	nsubj
11	have	VBP	12	aux
12	shown	VBN	8	ccomp
13	``	``	12	punct
14	excellent	JJ	15	amod
15	growth	NN	12	dobj
16	.	.	8	punct
17	''	''	8	punct

1	Lilly	NNP	2	nn
2	officials	NNS	3	nsubj
3	said	VBD	0	root
4	they	PRP	6	nsubj
5	had	VBD	6	aux
6	seen	VBN	3	ccomp
7	reports	NNS	6	dobj
8	of	IN	7	prep
9	hypoglycemic	JJ	10	amod
10	unawareness	NN	8	pobj
11	among	IN	10	prep
12	some	DT	13	det
13	patients	NNS	11	pobj
14	making	VBG	13	partmod
15	the	DT	16	det
16	shift	NN	14	dobj
17	from	IN	16	prep
18	animal	JJ	17	pobj
19	to	TO	16	prep
20	human	JJ	21	amod
21	insulin	NN	19	pobj
22	,	,	3	punct
23	but	CC	3	cc
24	did	VBD	26	aux
25	n't	RB	26	neg
26	know	VB	3	conj
27	if	IN	31	mark
28	the	DT	29	det
29	problem	NN	31	nsubj
30	had	VBD	31	aux
31	caused	VBN	26	advcl
32	any	DT	33	det
33	deaths	NNS	31	dobj
34	.	.	3	punct

1	Dr.	NNP	3	nn
2	Leigh	NNP	3	nn
3	Thompson	NNP	11	nsubj
4	,	,	3	punct
5	a	DT	9	det
6	Lilly	NNP	7	nn
7	group	NN	9	nn
8	vice	NN	9	nn
9	president	NN	3	appos
10	,	,	3	punct
11	said	VBD	0	root
12	the	DT	13	det
13	company	NN	16	poss
14	's	POS	13	possessive
15	clinical	JJ	16	amod
16	trials	NNS	24	nsubj
17	of	IN	16	prep
18	both	CC	23	dep
19	its	PRP$	23	poss
20	animal	JJ	23	amod
21	and	CC	20	cc
22	human-based	JJ	20	conj
23	insulins	NNS	17	pobj
24	indicated	VBD	11	ccomp
25	no	DT	26	det
26	difference	NN	24	dobj
27	in	IN	26	prep
28	the	DT	29	det
29	level	NN	27	pobj
30	of	IN	29	prep
31	hypoglycemia	NN	30	pobj
32	between	IN	26	prep
33	users	NNS	32	pobj
34	of	IN	33	prep
35	either	DT	36	det
36	product	NN	34	pobj
37	.	.	11	punct

1	Dr.	NNP	2	nn
2	Toseland	NNP	3	nsubj
3	said	VBD	0	root
4	most	JJS	13	nsubj
5	of	IN	4	prep
6	the	DT	8	det
7	British	JJ	8	amod
8	diabetics	NNS	5	pobj
9	who	WP	10	nsubj
10	died	VBD	4	rcmod
11	had	VBD	13	aux
12	been	VBN	13	aux
13	taking	VBG	3	ccomp
14	a	DT	16	det
15	human-based	JJ	16	amod
16	insulin	NN	13	dobj
17	made	VBN	16	partmod
18	by	IN	17	prep
19	Novo\/Nordisk	NNP	18	pobj
20	,	,	19	punct
21	a	DT	23	det
22	Danish	JJ	23	amod
23	manufacturer	NN	19	appos
24	.	.	3	punct

1	None	NN	6	nsubj
2	of	IN	1	prep
3	the	DT	4	det
4	diabetics	NNS	2	pobj
5	were	VBD	6	aux
6	using	VBG	0	root
7	Lilly	NNP	9	poss
8	's	POS	7	possessive
9	insulin	NN	6	dobj
10	.	.	6	punct


